Performance of ZLAB Zai Lab | -42.1% in 12m
Compare ZLAB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Zai Lab with its related Sector/Index XBI
Performance Duell ZLAB vs XBI
| TimeFrame | ZLAB | XBI |
|---|---|---|
| 1 Day | -2.66% | -1.52% |
| 1 Week | -3.39% | 3.45% |
| 1 Month | 41.4% | 7.71% |
| 3 Months | -6.01% | -2.11% |
| 6 Months | -29.6% | 25.51% |
| 12 Months | -42.1% | 6.37% |
| YTD | -25.6% | 1.05% |
| Rel. Perf. 1m | 2.62 | |
| Rel. Perf. 3m | -3.12 | |
| Rel. Perf. 6m | -6.02 | |
| Rel. Perf. 12m | -5.61 |
Is Zai Lab a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Zai Lab (NASDAQ:ZLAB) is currently (May 2024)
not a good stock to buy. It has a ValueRay Fundamental Rating of -48.82 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZLAB as of May 2024 is 16.10. This means that ZLAB is currently overvalued and has a potential downside of -17.01% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZLAB as of May 2024 is 16.10. This means that ZLAB is currently overvalued and has a potential downside of -17.01% (Sold with Premium).
Is ZLAB a buy, sell or hold?
- Strong Buy: 7
- Buy: 4
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: ZLAB is performing better - Values below 0%: ZLAB is underperforming
Compare ZLAB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.04% | 35.63% | -47.92% | -71.44% |
| US NASDAQ 100 | QQQ | -5.58% | 35.31% | -47.10% | -79.44% |
| US Dow Jones Industrial 30 | DIA | -4.75% | 35.23% | -45.10% | -64.11% |
| German DAX 40 | DBXD | -2.99% | 36.43% | -46.62% | -58.86% |
| UK FTSE 100 | ISFU | -4.89% | 31.60% | -46.49% | -57.46% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.50% | 36.88% | -32.96% | -34.42% |
| Hongkong Hang Seng | HSI | -7.12% | 18.12% | -34.67% | -36.73% |
| Japan Nikkei 225 | EXX7 | -3.76% | 41.90% | -41.12% | -53.90% |
| India NIFTY 50 | INDA | -6.50% | 37.48% | -47.21% | -70.81% |
| Brasil Bovespa | EWZ | -3.83% | 36.16% | -27.80% | -54.42% |
ZLAB Zai Lab vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.39% | 38.09% | -48.14% | -79.57% |
| Consumer Discretionary | XLY | -3.73% | 37.70% | -36.97% | -61.76% |
| Consumer Staples | XLP | -4.15% | 34.82% | -43.87% | -47.67% |
| Energy | XLE | -4.59% | 40.52% | -43.75% | -67.31% |
| Financial | XLF | -4.97% | 34.35% | -52.05% | -75.16% |
| Health Care | XLV | -5.28% | 35.72% | -44.64% | -55.59% |
| Industrial | XLI | -3.11% | 37.92% | -49.32% | -70.42% |
| Materials | XLB | -3.73% | 37.86% | -45.65% | -62.71% |
| Real Estate | XLRE | -5.90% | 32.92% | -39.27% | -52.07% |
| Technology | XLK | -6.45% | 34.88% | -45.95% | -80.40% |
| Utilities | XLU | -4.89% | 28.51% | -47.83% | -54.77% |
| Aerospace & Defense | XAR | -4.16% | 32.94% | -45.17% | -66.24% |
| Biotech | XBI | -6.84% | 33.69% | -55.14% | -48.46% |
| Homebuilder | XHB | -3.07% | 35.06% | -60.14% | -92.94% |
| Retail | XRT | -5.47% | 33.94% | -50.47% | -67.28% |
Does Zai Lab outperform its market, is ZLAB a Sector Leader?
No, over the last 12 months Zai Lab (ZLAB) made -42.09%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months ZLAB made -6.01%, while XBI made -2.11%.
No, over the last 12 months Zai Lab (ZLAB) made -42.09%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months ZLAB made -6.01%, while XBI made -2.11%.
| Period | ZLAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 41.40% | 7.71% | 5.77% |
| 3 Months | -6.01% | -2.11% | 6.32% |
| 12 Months | -42.09% | 6.37% | 29.35% |